In last trading session, Coeptis Therapeutics Holdings Inc (NASDAQ:COEP) saw 2.95 million shares changing hands with its beta currently measuring -0.90. Company’s recent per share price level of $0.18 trading at -$0.03 or -16.07% at ring of the bell on the day assigns it a market valuation of $7.29M. That closing price of COEP’s stock is at a discount of -438.89% from its 52-week high price of $0.97 and is indicating a premium of 16.67% from its 52-week low price of $0.15. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.88 million shares which gives us an average trading volume of 429.67K if we extend that period to 3-months.

Coeptis Therapeutics Holdings Inc (NASDAQ:COEP) trade information

Upright in the red during last session for losing -16.07%, in the last five days COEP remained trading in the red while hitting it’s week-highest on Wednesday, 12/18/24 when the stock touched $0.18 price level, adding 24.59% to its value on the day. Coeptis Therapeutics Holdings Inc’s shares saw a change of -77.41% in year-to-date performance and have moved -4.06% in past 5-day. Coeptis Therapeutics Holdings Inc (NASDAQ:COEP) showed a performance of -9.64% in past 30-days. Number of shares sold short was 0.15 million shares which calculate 0.4 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -311.69% during past 5 years.

Coeptis Therapeutics Holdings Inc (NASDAQ:COEP)’s Major holders

Insiders are in possession of 18.53% of company’s total shares while institution are holding 4.28 percent of that, with stock having share float percentage of 5.25%. Investors also watch the number of corporate investors in a company very closely, which is 4.28% institutions for Coeptis Therapeutics Holdings Inc that are currently holding shares of the company.